Visioneering Technologies Inc

Healthcare AU VTI

0.1AUD
-(-%)

Last update at 2024-05-07T02:26:00Z

Day Range

0.100.10
LowHigh

52 Week Range

0.100.42
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -5.84800M -2.32900M -9.23600M -12.60800M -16.73500M
Minority interest - - - - -
Net income -5.85400M -2.33400M -9.23900M -12.61700M -16.73500M
Selling general administrative 2.42M 3.19M 3.32M 3.39M 4.08M
Selling and marketing expenses 3.64M 4.90M 5.18M 9.15M 10.13M
Gross profit 3.32M 2.97M 2.22M 1.97M -0.07900M
Reconciled depreciation 0.02M 0.03M 0.05M 0.07M 0.08M
Ebit -5.55200M -2.00700M -8.03700M -12.73100M -16.73500M
Ebitda -5.52800M -1.97800M -8.84800M -12.37600M -16.65904M
Depreciation and amortization 0.02M 0.03M -0.81100M 0.35M 0.08M
Non operating income net other - - - - -
Operating income -5.55200M -2.00700M -8.03700M -12.73100M -16.99096M
Other operating expenses 13.11M 14.45M 12.87M 18.45M 20.28M
Interest expense 0.30M 0.32M 0.33M 0.16M 0.00000M
Tax provision 0.00600M 0.00500M 0.00390M 0.00900M 0.00000M
Interest income 0.07M 4.02M 0.01M 0.05M 0.18M
Net interest income -0.22300M -0.32200M -0.42197M -0.10562M 0.26M
Extraordinary items - - - - 0.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00600M 0.00500M 0.00300M 0.00900M 0.00000M
Total revenue 7.29M 7.15M 5.11M 5.72M 3.29M
Total operating expenses 9.14M 10.26M 9.99M 14.69M 16.91M
Cost of revenue 3.97M 4.19M 2.88M 3.75M 3.37M
Total other income expense net -0.29600M -0.32200M -1.19900M 0.12M 0.26M
Discontinued operations - - - - -
Net income from continuing ops -5.85400M -2.33400M -11.99559M -18.00885M -23.71068M
Net income applicable to common shares -5.85400M -2.33400M -9.23900M -12.61700M -16.73500M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets - 9.11M 14.91M 4.99M 5.83M
Intangible assets - 0.15M 0.16M 0.18M 0.15M
Earning assets - - - - -
Other current assets -4.39511M 0.96M 1.15M 0.52M 0.20M
Total liab - 2.81M 4.87M 6.69M 4.85M
Total stockholder equity - 6.29M 10.04M -1.70500M 0.98M
Deferred long term liab - - - - -
Other current liab - 1.03M 1.58M 2.38M 1.50M
Common stock - 95.31M 93.20M 79.12M 72.57M
Capital stock - 95.31M 93.20M 79.12M 72.57M
Retained earnings - -89.01100M -83.15700M -80.82300M -71.58400M
Other liab - 0.17M 0.00900M - 0.21M
Good will - - - - -
Other assets - 0.21M 0.20M 0.18M 0.20M
Cash 0.37M 3.12M 10.98M 2.41M 1.92M
Cash and equivalents - 3.12M 10.98M 2.41M 1.92M
Total current liabilities - 1.39M 2.12M 2.71M 1.78M
Current deferred revenue - - - - -
Net debt -0.36638M -1.90800M -8.24400M 0.42M 0.94M
Short term debt - 0.00000M 0.00000M 0.00000M 0.00000M
Short long term debt - - - - -
Short long term debt total - 1.21M 2.74M 2.83M 2.86M
Other stockholder equity - - - - 0.24M
Property plant equipment - 0.26M 0.11M 0.21M 0.32M
Total current assets - 8.49M 14.45M 4.42M 5.16M
Long term investments - - - - -
Net tangible assets - 6.15M 9.88M -1.88200M 0.83M
Short term investments 4.03M 1.84M - - -
Net receivables - 0.73M 0.91M 0.94M 0.83M
Long term debt - 1.21M 2.74M 3.67M 2.86M
Inventory - 1.86M 1.41M 0.55M 2.21M
Accounts payable - 0.36M 0.54M 0.33M 0.28M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -0.24265M
Additional paid in capital - - - - -
Common stock total equity - - - 102.72M 103.58M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.21M 0.20M 0.18M 0.20M
Deferred long term asset charges - - - - -
Non current assets total - 0.61M 0.47M 0.56M 0.67M
Capital lease obligations - - - - -
Long term debt total - 1.21M 2.74M 3.87M 2.86M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.84200M -0.01900M -0.03116M -0.00143M -0.02409M
Change to liabilities -0.18700M 0.21M 0.05M 0.14M -0.02400M
Total cashflows from investing activities -1.84200M -0.01900M -0.02400M -0.00100M -0.01700M
Net borrowings -0.04300M -0.07300M 1.03M 3.00M 3.00M
Total cash from financing activities -0.04300M 16.60M 7.02M 7.30M 8.86M
Change to operating activities 0.10M -0.13200M -1.07000M 0.09M 0.40M
Net income -5.85400M -2.33400M -9.23900M -12.61700M -16.73500M
Change in cash -7.86800M 8.58M 0.49M -5.35600M -13.18929M
Begin period cash flow 10.98M 2.41M 1.92M 7.28M 23.50M
End period cash flow 3.12M 10.98M 2.41M 1.92M 10.31M
Total cash from operating activities -5.83000M 0.03M -6.50800M -12.65100M -15.54700M
Issuance of capital stock - 16.67M 5.70M 4.33M 6.25M
Depreciation 0.02M 0.03M 0.05M 0.07M 0.08M
Other cashflows from investing activities -1.83800M 0.00000M - 0.00000M -0.00700M
Dividends paid - - - - -
Change to inventory -0.44900M -0.85800M 1.66M -0.18900M -0.09500M
Change to account receivables 0.18M 0.04M -0.10900M -0.34000M -0.25300M
Sale purchase of stock 0.00000M 16.67M 5.99M 4.33M 6.25M
Other cashflows from financing activities -1.84200M -0.01900M 1.32M 2.96M -22.02749M
Change to netincome 0.06M -5.08300M 2.03M 0.18M 1.08M
Capital expenditures 0.00400M 0.02M 0.02M 0.00100M 0.02M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.35600M -0.74100M 0.53M -0.30300M 0.03M
Stock based compensation - - - - -
Other non cash items 5.83M 2.31M 9.19M 12.55M 16.66M
Free cash flow -5.83400M -0.01900M -0.02400M -0.00100M -22.05157M

Fundamentals

  • Previous Close 0.10
  • Market Cap5.32M
  • Volume300
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.96300M
  • Revenue TTM8.67M
  • Revenue Per Share TTM0.25
  • Gross Profit TTM 0.27M
  • Diluted EPS TTM-0.15

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
VTI
Visioneering Technologies Inc
- -% 0.10 - - 1.12 1.10 0.74 -1.9198
COH
Cochlear Ltd
0.13 0.04% 327.94 59.34 46.30 9.75 11.76 9.62 36.63
PNV
Polynovo Ltd
0.17 8.02% 2.29 - 140.85 17.37 21.49 17.51 647.42
AVR
Anteris Technologies Ltd
0.03 0.14% 21.03 - - 104.23 14.98 95.15 -5.9152
AVH
Avita Therapeutics Inc
0.19 6.83% 2.97 - - 8.59 5.71 6.72 -10.0538

Reports Covered

Stock Research & News

Profile

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal one-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

Visioneering Technologies Inc

30 Mansell Court, Alpharetta, GA, United States, 30076

Key Executives

Name Title Year Born
Mr. Brian D. Lane CPA Chief Operating & Chief Financial Officer 1962
Mr. Tony Sommer Jr. Sr. VP of Sales & Marketing NA
Dr. Kuang-Mon Tuan FAAO, Ph.D. Chief Medical Officer NA
Dr. Richard A. Griffin Founder & Medical Adviser NA
Ms. Layna L. Mendlinger Global Head of Marketing NA
Ms. Leanne Ralph AAICD, ACIS, BBus Company Sec. NA
Dr. Douglas P. Benoit OD, FAAO Exec. Director of Professional Affairs NA
Dr. Juan Carlos Aragon CEO & Executive Director NA
Ms. Leanne Ralph AAICD, ACIS, BBus Company Secretary NA
Dr. Juan Carlos Aragon CEO & Executive Director NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).